These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37264496)

  • 61. Paediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countries.
    Kajungu DK; Erhart A; Talisuna AO; Bassat Q; Karema C; Nabasumba C; Nambozi M; Tinto H; Kremsner P; Meremikwu M; D'Alessandro U; Speybroeck N
    PLoS One; 2014; 9(5):e96388. PubMed ID: 24787710
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development of a drug risk analysis and assessment system and its application in signal excavation and analysis of 263 cases of fluoroquinolone-induced adverse reactions.
    Guan Y; Ji L; Zheng L; Yang J; Qin Y; Ding N; Miao T; Liu X
    Front Pharmacol; 2022; 13():892503. PubMed ID: 36267271
    [No Abstract]   [Full Text] [Related]  

  • 63. Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs.
    Bate A; Lindquist M; Orre R; Edwards IR; Meyboom RH
    Eur J Clin Pharmacol; 2002 Oct; 58(7):483-90. PubMed ID: 12389072
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Examining the Nocebo Effect of Statins Through Statin Adverse Events Reported in the Food and Drug Administration Adverse Event Reporting System.
    Moon J; Cohen Sedgh R; Jackevicius CA
    Circ Cardiovasc Qual Outcomes; 2021 Jan; 14(1):e007480. PubMed ID: 33161769
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Signal detection in FDA AERS database using Dirichlet process.
    Hu N; Huang L; Tiwari RC
    Stat Med; 2015 Aug; 34(19):2725-42. PubMed ID: 25924820
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature.
    Roberto G; Biagi C; Montanaro N; Koci A; Moretti U; Motola D
    Eur J Clin Pharmacol; 2012 Jun; 68(6):1007-11. PubMed ID: 22286160
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Extended multi-item gamma Poisson shrinker methods based on the zero-inflated Poisson model for postmarket drug safety surveillance.
    Heo SJ; Jung I
    Stat Med; 2020 Dec; 39(30):4636-4650. PubMed ID: 32910522
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting system.
    Wen H; Lu C; Zhang M; Qi X
    Expert Opin Drug Saf; 2023; 22(11):1133-1142. PubMed ID: 37578751
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Data Mining for Adverse Drug Events With a Propensity Score-matched Tree-based Scan Statistic.
    Wang SV; Maro JC; Baro E; Izem R; Dashevsky I; Rogers JR; Nguyen M; Gagne JJ; Patorno E; Huybrechts KF; Major JM; Zhou E; Reidy M; Cosgrove A; Schneeweiss S; Kulldorff M
    Epidemiology; 2018 Nov; 29(6):895-903. PubMed ID: 30074538
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Assessing taxane-associated adverse events using the FDA adverse event reporting system database.
    Lao DH; Chen Y; Fan J; Zhang JZ
    Chin Med J (Engl); 2021 Jun; 134(12):1471-1476. PubMed ID: 34074841
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System.
    Jiao XF; Li HL; Jiao XY; Guo YC; Zhang C; Yang CS; Zeng LN; Bo ZY; Chen Z; Song HB; Zhang LL
    Sci Rep; 2020 Jul; 10(1):11955. PubMed ID: 32686733
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Statins and musculoskeletal conditions, arthropathies, and injuries.
    Mansi I; Frei CR; Pugh MJ; Makris U; Mortensen EM
    JAMA Intern Med; 2013 Jul; 173(14):1-10. PubMed ID: 23877079
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A data mining approach for signal detection and analysis.
    Bate A; Lindquist M; Edwards IR; Orre R
    Drug Saf; 2002; 25(6):393-7. PubMed ID: 12071775
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Risk predictive models of healthcare-seeking delay among imported malaria patients in Jiangsu Province based on the machine learning].
    Zhang Y; Cao Y; Yang K; Wang W; Yang M; Chai L; Gu J; Li M; Lu Y; Zhou H; Zhu G; Cao J; Lu G
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Jun; 35(3):225-235. PubMed ID: 37455092
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods.
    Schuemie MJ; Coloma PM; Straatman H; Herings RM; Trifirò G; Matthews JN; Prieto-Merino D; Molokhia M; Pedersen L; Gini R; Innocenti F; Mazzaglia G; Picelli G; Scotti L; van der Lei J; Sturkenboom MC
    Med Care; 2012 Oct; 50(10):890-7. PubMed ID: 22929992
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Development and Validation of Algorithms to Identify Statin Intolerance in a US Administrative Database.
    Schulman KL; Lamerato LE; Dalal MR; Sung J; Jhaveri M; Koren A; Mallya UG; Foody JM
    Value Health; 2016; 19(6):852-860. PubMed ID: 27712714
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Are all quantitative postmarketing signal detection methods equal? Performance characteristics of logistic regression and Multi-item Gamma Poisson Shrinker.
    Berlin C; Blanch C; Lewis DJ; Maladorno DD; Michel C; Petrin M; Sarp S; Close P
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):622-30. PubMed ID: 21994119
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluating performance of electronic healthcare records and spontaneous reporting data in drug safety signal detection.
    Patadia VK; Schuemie MJ; Coloma P; Herings R; van der Lei J; Straus S; Sturkenboom M; Trifirò G
    Int J Clin Pharm; 2015 Feb; 37(1):94-104. PubMed ID: 25488315
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adverse events of guselkumab in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system.
    Xiang DC; Chen W; Fu ZW; Wu XH; Gao P; Wu Y
    Expert Opin Drug Saf; 2023; 22(10):943-955. PubMed ID: 37294594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.